查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2092764

生醫植入市場：依移植類型、手術類型、應用、最終用戶、國家及地區分類－全球產業分析、市場規模、市場佔有率及2026年至2033年預測

Biological Implants Market, By Graft, By Procedure Type, By Application, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
出版日期: | 出版商: AnalystView Market Insights | 英文 303 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2025 年，生物醫學植入市場價值將達到 95.603 億美元，並預計從 2026 年到 2033 年將以 6.8% 的複合年成長率成長。

生物醫學植入係指經由外科手術植入人體內的醫療設備，其由天然人體組織、動物性生物材料或生物工程生物材料製成。與合成植入不同，生物醫學植入能夠主動參與人體的生理過程，促進組織再生、細胞整合和生物相容性。生物植入的典型例子包括骨移植、生物醫學心臟瓣膜、去細胞真皮基質（ADM）、膠原蛋白支架、生物網膜、角膜移植、肌腱和韌帶移植以及組織工程植入。

由於肌肉骨骼疾病、心血管疾病、創傷、慢性傷口和退化性疾病的盛行率不斷上升，市場正經歷穩定成長。再生醫學需求的成長、組織工程的創新、器官和組織移植的積極發展以及生物相容性植入的普及也推動了市場成長。細胞外基質技術、幹細胞技術、去細胞技術、3D列印和組織支架生物工程的進步正在提高植入的性能。此外，醫療保健成本的上升和先進外科技術的普及也促進了植入在整形外科、心血管、重組外科、牙科、眼科和創傷治療等領域的廣泛應用。

生物植入市場－市場動態

肌肉骨骼疾病負擔日益加重和醫療保健成本不斷上漲正在推動市場成長。

整形外科、心血管、慢性傷口、燒燙傷、運動傷害和重組手術數量的不斷成長，顯著推動了全球市場對生物來源植入的需求。根據世界衛生組織統計，全球約有17.1億人患有肌肉骨骼疾病。這些疾病是導致殘疾的主要原因，而背痛在160個國家持續流行，也推動了生物來源植入的應用。與合成植入物相比，生物基植入因其良好的生物相容性、促進組織再生的能力以及更低的慢性發炎風險，在各種類型的植入中都備受青睞。此外，老年人口的快速成長也推動了市場需求，因為老年人患有骨質疏鬆症、骨關節炎、脊椎退化性疾病、心臟瓣膜疾病和慢性傷口問題的風險更高。最後，微創植入的日益普及也促進了對生物基植入的需求，因為微創手術具有更優異的組織整合性、更快的恢復速度以及更低的感染和再次手術風險。

除了醫療保健支出不斷成長外，再生醫學領域的技術創新也將推動市場成長。根據歐盟統計局的數據，2023年歐盟醫療保健支出達到1.72兆歐元，佔歐盟GDP的10.0%。同時，人均醫療保健支出從2014年的2,668歐元增至2023年的3,835歐元，增幅達43.7%。這些支出正在建立該領域強大的基礎設施，並提供先進植入技術。同時，美國國立衛生研究院（NIH）繼續致力於再生醫學和組織工程的研究，以促進用於組織替代和再生的生物材料、幹細胞技術和組織工程的發展。組織保存、滅菌、供體組織製備、細胞外基質工程和生物活性支架等方面的創新正在推動下一代生物植入的開發。

生物植入市場－市場區隔分析：

全球生物植入市場按移植類型、手術類型、應用、最終用戶和地區進行細分。

從產品細分市場來看，由於同種異體移植在整形外科、牙科、心血管外科和重組外科等領域的廣泛臨床應用，其在生物植入中佔據了相當大的佔有率。同種異體移植的優點在於，它不會像自體移植那樣在供體部位造成額外的創傷，從而減少供體部位的併發症，並促進有效的組織支持和再生。組織庫、滅菌技術和捐贈者評估的進步，使得同種異體移植的使用更加安全。根據美國衛生資源和服務部 (HRSA) 統計，美國每年進行超過一百萬例組織移植手術，包括骨骼、肌腱、皮膚、心臟瓣膜和角膜等。

從應用領域來看，鑑於肌肉骨骼疾病、骨質疏鬆症、骨折、運動傷害和骨關節炎的日益普遍，整形外科在生物植入市場中佔據最大佔有率。根據世界衛生組織估計，全球約有17.1億人患有肌肉骨骼疾病，是造成各種殘疾的主要原因。包括脊椎融合手術、骨骼修復、人工關節重建和韌帶修復術在內的手術數量持續成長，導致生物來源的骨和肌腱移植物的使用量不斷增加。此外，心血管領域也佔了相當大的佔有率，每年有1,790萬人死於心血管疾病。然而，由於生物植入具有良好的生物相容性和再生特性，其在牙科、創傷護理、重組外科、眼科、疝氣修補術和運動醫學等領域的應用正在迅速擴展。

生物來源植入市場—區域分析

生物來源植入市場由北美主導。這主要歸功於該地區先進的醫療保健體系、高昂的醫療費用支出、完善的組織庫系統、優惠的報銷政策以及再生醫學技術的快速普及。北美地區每年進行大量的整形外科、心血管、重組、牙科和創傷護理手術，對生物基植入產生了穩定的需求。根據美國疾病管制與預防中心（CDC）統計，美國約四分之三的成年人患有至少一種慢性疾病，一半的成年人患有兩種或兩種以上的慢性疾病。在65歲及以上的老年人中，約有90%患有至少一種慢性疾病；35-64歲人群的這一比例超過75%；18-34歲人群的這一比例超過60%。包括心血管疾病、關節炎、糖尿病和肥胖症在內的各種慢性疾病的日益流行，推動了對生物移植、再生醫學植入和組織療法的需求不斷成長。

由於醫療保健支出不斷成長、法規環境有利、擁有先進的組織庫設施以及再生醫學領域投資不斷擴大，歐洲對全球生物植入市場做出了重大貢獻。根據歐盟委員會統計，歐盟成員國共有3492個獲得許可的組織庫設施，以確保用於移植和生物植入手術的人體組織和細胞的正確收集、處理、儲存和分發。這些設施促進了生物植入的大規模應用。此外，微創手術的日益普及、整形外科和心血管手術數量的增加以及對生物心臟瓣膜和軟組織重組產品需求的成長，都在推動市場成長。在該地區，德國、法國、英國、義大利和西班牙憑藉著完善的醫療保健基礎設施和生物醫學研究，引領市場發展。

目錄

第1章：生物醫學植入市場概述

  • 分析範圍
  • 市場估算期

第2章執行摘要

  • 市場區隔
  • 競爭考察

第3章：生物醫學植入的主要市場趨勢

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 未來市場趨勢

第4章：生物醫學植入產業分析

  • PEST分析
  • 波特五力分析
  • 市場成長前景展望圖
  • 管理體制分析

第5章：生物醫學植入市場：地緣政治緊張局勢加劇的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：生物醫學植入市場的現狀

  • 2025年生物醫學植入市場佔有率分析
  • 主要製造商的細分數據
    • 對現有公司的分析
    • 新興企業分析

第7章：生物醫學植入市場：依移植類型分類

  • 概述
    • 細分市場佔有率分析：依移植類型
    • 自體移植
    • 同種異體移植
    • 異質骨移植
    • 生物工程/組織工程植入
    • 其他

第8章：生物醫學植入市場：依手術類型分類

  • 概述
    • 基於細分市場的市場佔有率分析：按手術類型
    • 透過開放式手術植入植入
    • 微創植入手術
    • 經經皮注射給藥
    • 其他

第9章：生物醫學植入市場：依應用領域分類

  • 概述
    • 基於細分市場的市場佔有率分析：按應用領域
    • 整形外科和脊柱
      • 骨重組與骨融合
      • 關節和軟骨修復
      • 運動醫學
    • 心血管系統
    • 口腔顎顏面
    • 創傷護理
    • 整形和重組外科
    • 疝氣和軟組織修復
    • 眼科
    • 其他

第10章：生物醫學植入市場：依最終用戶分類

  • 概述
    • 基於細分市場的市場佔有率分析：按手術類型
    • 醫院
    • 門診手術中心（ASC）
    • 專科診所
    • 牙醫診所
    • 研究和學術機構
    • 其他

第11章：生物醫學植入市場：按地區分類

  • 介紹
  • 北美洲
    • 概述
    • 主要製造商：北美
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 主要製造商：歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 丹麥
    • 其他歐洲國家
  • 亞太地區
    • 概述
    • 主要製造商：亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 台灣
    • 越南
    • 其他亞太國家
  • 拉丁美洲
    • 概述
    • 主要製造商：拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他拉丁美洲國家
  • 中東和非洲
    • 概述
    • 主要生產商：中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 伊朗
    • 卡達
    • 其他中東和非洲國家

第12章：主要供應商分析：生物醫學植入產業

  • 競爭基準
    • 競爭對手儀錶板
    • 競爭定位
  • 公司簡介
    • Medtronic plc
    • Johnson & Johnson-DePuy Synthes
    • Stryker Corporation
    • Zimmer Biomet Holdings, Inc.
    • Smith+Nephew plc
    • Edwards Lifesciences Corporation
    • Baxter International Inc.
    • Integra LifeSciences Holdings Corporation
    • Organogenesis Holdings Inc.
    • MTF Biologics
    • LifeNet Health
    • RTI Surgical
    • Orthofix Medical Inc.
    • Globus Medical, Inc.
    • AbbVie Inc.-LifeCell
    • Vericel Corporation
    • MiMedx Group, Inc.
    • Elutia Inc.
    • Cook Biotech Incorporated*
    • Geistlich Pharma AG
    • CollPlant Biotechnologies Ltd.
    • Bioventus Inc.
    • CONMED Corporation
    • Artivion, Inc.
    • LeMaitre Vascular, Inc.
    • Abbott Laboratories
    • B. Braun SE
    • Coloplast A/S
    • Straumann Holding AG
    • Dentsply Sirona Inc.
    • Xtant Medical Holdings, Inc.
    • Others

第13章：AnalystView 的全景視圖

簡介目錄
Product Code: ANV7000

Biological Implants Market size was valued at US$ 9,560.3 Million in 2025, expanding at a CAGR of 6.8% from 2026 to 2033.

Biological Implants are the medical devices which are surgically implanted into the body and are made from natural human tissue, biological materials of animal origin, or bioengineered biological materials. In contrast to synthetic implants, biological implants actively interact with physiological processes of the human body, facilitating tissue regeneration, cellular integration and biocompatibility. Bone grafts, biological heart valves, ADMs, collagen-based scaffolds, biologic meshes, corneal grafts, tendons/ligaments grafts, tissue engineered implants are typical examples of biological implants.

The market witness's stable growth due to increasing prevalence of musculoskeletal disorders, cardiovascular diseases, trauma, chronic wounds, and degenerative diseases. Increasing demand for regenerative medicine, innovations in tissue engineering, active development of organ and tissue transplantations, and popularity of biocompatible implants are additional factors which are propelling market growth. Advancements in extracellular matrix technologies, stem cell technology, decellularization techniques, 3D printing, and bioengineering of tissue scaffolds provide better performance of biological implants. Moreover, higher health care spending and more access to advanced surgical techniques have been contributing to the growth in the use of biological implants in orthopedic, cardiovascular, reconstructive, dental, ocular, and wound healing applications.

Biological Implants Market- Market Dynamics

Rising Burden of Musculoskeletal Disorders and Increasing Healthcare Expenditure Driving Market Growth

The growing number of orthopedic disorders, cardiovascular diseases, chronic wounds, burns, sports injuries, and reconstructive surgeries is greatly fueling the need for biological implants in the global market. According to the WHO, nearly 1.71 billion people suffering from musculoskeletal disorders all over the world. They are the major reasons of disabilities; low back pain remains the major factor of disability in 160 countries, which promotes the usage of biological implants. Being highly biocompatible and able to promote tissue regeneration and having fewer risks of chronic inflammation compared to synthetic implants, biological implants are preferred in various types of surgeries. Moreover, the fast-growing population of older adults increases the demand of the market, since they are at higher risk of osteoporosis, osteoarthritis, degenerative disorders of the spine, heart valve diseases, and chronic wound problems. Finally, the increasing tendency towards the minimally invasive procedures is fostering the need of biological implants because of their better tissue integration, quicker recovery, low risk of infection, and revision rate.

Rising health care expenditures along with innovations in the field of regenerative medicine will add impetus to the market growth. According to the Eurostat, the expenditure on health care in the European Union was recorded at €1.72 trillion in 2023, which accounted for 10.0% of EU GDP, while per capita expenditure on health care rose from €2,668 in 2014 to €3,835 in 2023, indicating an increase of 43.7%. These expenditures are building a robust infrastructure in the sector and providing access to advanced implant technologies. In parallel, the NIH continues to emphasize research into regenerative medicine and tissue engineering to promote the development of biomaterials, stem cell technology, and tissue engineering for tissue replacement and regeneration. Innovations in the areas of tissue preservation, sterilization, donor tissue preparation, extracellular matrix engineering, and bioactive scaffolds have enabled the development of the next generation of biological implants.

Biological Implants Market- Segmentation Analysis:

The Global Biological Implants Market is segmented on the basis of Graft, Procedure Type, Application, End User, and Region.

In terms of product segmentation, allografts represent a significant portion of biological implants because of their extensive clinical application in orthopedic, dental, cardiovascular, and reconstructive surgeries. The advantage of using allografts lies in their ability to avoid additional wound in the donor area like in the case of autografts, which helps to reduce donor-site complications and deliver effective support and regrowth of the tissue. Improvements in tissue banking, sterilization techniques, and donor evaluation have made allografts even safer to use. As reported by the U.S. Health Resources and Services Administration (HRSA), more than 1 million tissue transplantations are conducted yearly in the United States, involving bone, tendons, skin, heart valves, and corneas.

Based on application segment, the largest share of the biological implants market is held by orthopedics due to an increasing prevalence of musculoskeletal diseases, osteoporosis, fractures, sports injuries, and degenerative joint diseases. WHO estimates that around 1.71 billion people all over the world suffer from musculoskeletal diseases and are the major cause of disabilities among all. The number of procedures such as spinal fusion, bone repair, joint replacement, ligament repair is growing continuously which results in an increased use of biological bone and tendon grafts. Moreover, the cardiovascular segment also holds a large share due to 17.9 million yearly death cases due to cardiovascular diseases. However, the adoption of biological implants in the segments such as dentistry, wound care, reconstructive surgery, ophthalmology, hernia repair, and sports medicine are rapidly growing due to their high biocompatibility and regenerative characteristics.

Biological Implants Market- Geographical Insights

The Biological Implants Market is dominated by North America owing to the region's sophisticated healthcare sector, substantial healthcare spending, well-developed tissue banking system, favorable reimbursement policies, and rapid adoption of regenerative technology. The North American region undertakes a wide number of orthopedic, cardiovascular, reconstructive, dental, and wound care surgeries every year, creating steady demand for biological implants. The CDC reports that around three out of four adults in the U.S. suffer from at least one chronic disease, while half of the adults in the country are affected by two or more chronic diseases. Among people aged above 65 years in the country, around 90 percent suffer from at least one chronic disease, which is greater than 75 percent among those aged between 35 years and 64 years and over 60 percent of those aged between 18 years and 34 years. The rising prevalence of various chronic diseases, including cardiovascular diseases, arthritis, diabetes, and obesity, creates increasing demand for biologic grafts, regenerative implants, and tissue-based therapies.

Europe is a notable contributor to the global Biological Implants Market due to the increase in spending on health care, positive regulatory environment, presence of advanced tissue banking facilities, and greater investments in regenerative medicine. The European Commission has stated that there are 3,492 licensed tissue establishments within Europe Union Member States to ensure the proper collection, processing, storage, and distribution of human tissues and cells used for transplantation and biological implants procedures. These facilities facilitate the use of biologic implants on a large scale. Moreover, the increased preference for minimally invasive surgical procedures, rise in orthopedic and cardiovascular surgeries, and growing demand for biological heart valves and soft tissue reconstructive products have been fueling the market growth with Germany, France, the UK, Italy, and Spain being the leaders in the region because of well-established healthcare infrastructure and biomedical research.

Biological Implants Market- Competitive Landscape:

The biological implants market enjoys fierce competition due to the existence of well-established firms producing medical devices, regenerative medicines and biomaterials with a wide array of biological grafts, acellular dermal matrices, collagen implants, biologic meshes and tissue engineering devices. Firms such as Medtronic plc, Stryker Corporation, Zimmer Biomet Holdings, Inc., Edwards Lifesciences Corporation and Smith+Nephew plc enjoy dominant positions in the industry thanks to their extensive product lines, international distribution channels, product innovation and investments in regenerative medicine, tissue engineering and biomaterial science.

According to NIH National Library of Medicine, more than 100,000 ACL reconstructive surgeries are done every year in the United States, out of which many surgeries employ biological implants like autografts and allografts in ligament reconstruction surgeries. The growing number of sports injuries and orthopedic diseases has continued to fuel the demand for innovative biological grafts and regenerative implants. Specialized firms such as LifeNet Health, MTF Biologics, Organogenesis Holdings Inc., Integra LifeSciences Holdings Corporation, and Cook Biotech Incorporated have helped increase market competition with the availability of allografts, xenografts, ECM products, and collagen-based regenerative products for orthopedic, cardiovascular, wound management, reconstructive, and sports medicine indications.

Recent Developments:

In February2026, CollPlant launched BioFlex, a ready-to-print rhCollagen-based kit for Digital Light Processing (DLP) 3D bioprinting. Designed for academic and industrial research, the platform supported the biofabrication of advanced tissue models, engineered tissues, and potential transplantable organs, strengthening the company's portfolio in tissue engineering, regenerative medicine, and biological biomaterials.

In March 2025, Cellino and Matricelf announced a strategic collaboration to accelerate the global biomanufacturing of personalized spinal cord injury treatments. The partnership combined Cellino's Nebula(TM) automated induced pluripotent stem cell (iPSC) manufacturing platform with Matricelf's double autologous 3D differentiation technology to advance scalable, patient-specific regenerative therapies for spinal cord repair.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BIOLOGICAL IMPLANTS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Medtronic plc
  • Johnson & Johnson - DePuy Synthes
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
  • Smith+Nephew plc
  • Edwards Lifesciences Corporation
  • Baxter International Inc.
  • Integra LifeSciences Holdings Corporation
  • Organogenesis Holdings Inc.
  • MTF Biologics
  • LifeNet Health
  • RTI Surgical
  • Orthofix Medical Inc.
  • Globus Medical, Inc.
  • AbbVie Inc. - LifeCell
  • Vericel Corporation
  • MiMedx Group, Inc.
  • Elutia Inc.
  • Cook Biotech Incorporated*
  • Geistlich Pharma AG
  • CollPlant Biotechnologies Ltd.
  • Bioventus Inc.
  • CONMED Corporation
  • Artivion, Inc.
  • LeMaitre Vascular, Inc.
  • Abbott Laboratories
  • B. Braun SE
  • Coloplast A/S
  • Straumann Holding AG
  • Dentsply Sirona Inc.
  • Xtant Medical Holdings, Inc.
  • Others

GLOBAL BIOLOGICAL IMPLANTS MARKET, BY GRAFT - MARKET ANALYSIS, 2020 - 2033

  • Autografts
  • Allografts
  • Xenografts
  • Bioengineered/Tissue-Engineered Implants
  • Others

GLOBAL BIOLOGICAL IMPLANTS MARKET, BY PROCEDURE TYPE - MARKET ANALYSIS, 2020 - 2033

  • Open Surgical Implantation
  • Minimally Invasive Implantation
  • Percutaneous/Injectable Delivery
  • Others

GLOBAL BIOLOGICAL IMPLANTS MARKET, BY APPLICATION - MARKET ANALYSIS, 2020 - 2033

  • Orthopedics and Spine
  • Bone Reconstruction and Fusion
  • Joint and Cartilage Repair
  • Sports Medicine
  • Cardiovascular
  • Dental and Maxillofacial
  • Wound Care
  • Plastic and Reconstructive Surgery
  • Hernia and Soft-Tissue Repair
  • Ophthalmology
  • Others

GLOBAL BIOLOGICAL IMPLANTS MARKET, BY END USER - MARKET ANALYSIS, 2020 - 2033

  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Specialty Clinics
  • Dental Clinics
  • Research & Academic Institutes
  • Others

GLOBAL BIOLOGICAL IMPLANTS MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Denmark
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Taiwan
  • Vietnam
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Iran
  • Qatar
  • Rest of MEA

Table of Contents

1. Biological Implants Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Biological Implants Market Snippet by Graft
    • 2.1.2. Biological Implants Market Snippet by Procedure Type
    • 2.1.3. Biological Implants Market Snippet by Application
    • 2.1.4. Biological Implants Market Snippet by End User
    • 2.1.5. Biological Implants Market Snippet by Country
    • 2.1.6. Biological Implants Market Snippet by Region
  • 2.2. Competitive Insights

3. Biological Implants Key Market Trends

  • 3.1. Biological Implants Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Biological Implants Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Biological Implants Market Opportunities
  • 3.4. Biological Implants Market Future Trends

4. Biological Implants Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Biological Implants Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Biological Implants Market Landscape

  • 6.1. Biological Implants Market Share Analysis, 2025
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Biological Implants Market - By Graft

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Graft, 2025 & 2033 (%)
    • 7.1.2. Autografts
    • 7.1.3. Allografts
    • 7.1.4. Xenografts
    • 7.1.5. Bioengineered/Tissue-Engineered Implants
    • 7.1.6. Others

8. Biological Implants Market - By Procedure Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Procedure Type, 2025 & 2033 (%)
    • 8.1.2. Open Surgical Implantation
    • 8.1.3. Minimally Invasive Implantation
    • 8.1.4. Percutaneous/Injectable Delivery
    • 8.1.5. Others

9. Biological Implants Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
    • 9.1.2. Orthopedics and Spine
      • 9.1.2.1. Bone Reconstruction and Fusion
      • 9.1.2.2. Joint and Cartilage Repair
      • 9.1.2.3. Sports Medicine
    • 9.1.3. Cardiovascular
    • 9.1.4. Dental and Maxillofacial
    • 9.1.5. Wound Care
    • 9.1.6. Plastic and Reconstructive Surgery
    • 9.1.7. Hernia and Soft-Tissue Repair
    • 9.1.8. Ophthalmology
    • 9.1.9. Others

10. Biological Implants Market - By End User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Procedure Type, 2025 & 2033 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Ambulatory Surgical Centers (ASCs)
    • 10.1.4. Specialty Clinics
    • 10.1.5. Dental Clinics
    • 10.1.6. Research & Academic Institutes
    • 10.1.7. Others

11. Biological Implants Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Biological Implants Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Biological Implants Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.17. Denmark
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.17.3. Poland Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
      • 11.3.17.4. Denmark Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.3.17.5. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.17.6. Denmark Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.18. Rest of Europe
      • 11.3.18.1. Overview
      • 11.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.18.3. Rest of the Europe Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
      • 11.3.18.4. Rest of the Europe Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.3.18.5. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.18.6. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Biological Implants Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.16. Taiwan
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.16.3. Taiwan Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
      • 11.4.16.4. Taiwan Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.4.16.5. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.16.6. Taiwan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.17. Vietnam
      • 11.4.17.1. Overview
      • 11.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.17.3. Vietnam Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
      • 11.4.17.4. Vietnam Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.4.17.5. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.17.6. Vietnam Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.18. Rest of APAC
      • 11.4.18.1. Overview
      • 11.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.18.3. Rest of APAC Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
      • 11.4.18.4. Rest of APAC Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.4.18.5. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.18.6. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Biological Implants Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Biological Implants Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.14. Iran
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.14.3. Iran Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
      • 11.6.14.4. Iran Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.6.14.5. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.14.6. Iran Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.15. Qatar
      • 11.6.15.1. Overview
      • 11.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.15.3. Qatar Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
      • 11.6.15.4. Qatar Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.6.15.5. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.15.6. Qatar Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.16. Rest of MEA
      • 11.6.16.1. Overview
      • 11.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.16.3. Rest of MEA Market Size and Forecast, By Graft, 2020 - 2033 (US$ Million)
      • 11.6.16.4. Rest of MEA Market Size and Forecast, By Procedure Type, 2020 - 2033 (US$ Million)
      • 11.6.16.5. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.16.6. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)

12. Key Vendor Analysis- Biological Implants Industry

  • 12.1. Competitive Benchmarking
    • 12.1.1. Competitive Dashboard
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Medtronic plc
    • 12.2.2. Johnson & Johnson - DePuy Synthes
    • 12.2.3. Stryker Corporation
    • 12.2.4. Zimmer Biomet Holdings, Inc.
    • 12.2.5. Smith+Nephew plc
    • 12.2.6. Edwards Lifesciences Corporation
    • 12.2.7. Baxter International Inc.
    • 12.2.8. Integra LifeSciences Holdings Corporation
    • 12.2.9. Organogenesis Holdings Inc.
    • 12.2.10. MTF Biologics
    • 12.2.11. LifeNet Health
    • 12.2.12. RTI Surgical
    • 12.2.13. Orthofix Medical Inc.
    • 12.2.14. Globus Medical, Inc.
    • 12.2.15. AbbVie Inc. - LifeCell
    • 12.2.16. Vericel Corporation
    • 12.2.17. MiMedx Group, Inc.
    • 12.2.18. Elutia Inc.
    • 12.2.19. Cook Biotech Incorporated*
    • 12.2.20. Geistlich Pharma AG
    • 12.2.21. CollPlant Biotechnologies Ltd.
    • 12.2.22. Bioventus Inc.
    • 12.2.23. CONMED Corporation
    • 12.2.24. Artivion, Inc.
    • 12.2.25. LeMaitre Vascular, Inc.
    • 12.2.26. Abbott Laboratories
    • 12.2.27. B. Braun SE
    • 12.2.28. Coloplast A/S
    • 12.2.29. Straumann Holding AG
    • 12.2.30. Dentsply Sirona Inc.
    • 12.2.31. Xtant Medical Holdings, Inc.
    • 12.2.32. Others

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us